Comparison of 3D MRI with high sampling efficiency and 2D multiplanar MRI for contouring in cervix cancer brachytherapy

Radiology and Oncology

Volumn 46, Issue 3, 2012, Pages 242-251

  Petric, Primoz ^a   Hudej, Robert ^a   Rogelj, Peter ^b   Blas, Mateja ^a   Segedin, Barbara ^a   Logar, Helena ^a   Dimopoulos, Johannes ^c  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b UNIVERSITY OF PRIMORSKA   (Slovenia)

^c METROPOLITAN HOSPITAL   (Greece)

Author keywords

brachytherapy; cervix cancer; contouring; MRI

Indexed keywords

ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE GUIDED RADIOTHERAPY; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; RELIABILITY; THREE DIMENSIONAL IMAGING; TWO DIMENSIONAL MULTIPLANAR NUCLEAR MAGNETIC RESONANCE IMAGING; UTERINE CERVIX CANCER;

EID: 84867310056     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/v10019-012-0023-1     Document Type: Article

References (59)

1. Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GECESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74: 235-45. (Pubitemid 40349132)
2. Pötter R, Haie-Mader C, Van Limbergen E, Barillot I, De Brabandere M, Dimpoulos J, et al. Recommendations from gynaecological (GYN) GECESTRO Working Group: (II): concepts and terms of 3D imaging, radiation physics, radiobiology, and 3D dose volume parameters. Radiother Oncol 2006; 78: 67-77.
3. Yadav P, Ramasubramanian V, Paliwal BR. Feasibility study on effect and stability of adaptive radiotherapy on kilovoltage cone beam CT. Radiol Oncol 2011; 45: 220-6.
4. Mayr NA, Montebello JF, Sorosky JI, Daugherty JS, Nguyen DL, Mardirossian G, et al. Brachytherapy management of the retroverted uterus using ultrasound-guided implant applicator placement. Brachytherapy 2005; 4: 24-9. (Pubitemid 40292826)
5. Sahinler I, Cepni I, Colpan D, Cepni K, Koksal S, Koca A, et al. Tandem application with transvaginal ultrasound guidance. Int J Radiat Oncol Biol Phys 2004; 59: 190-6. (Pubitemid 38501524)
6. Davidson MT, Yuen J, D'Souza D, Radwan JS, Hammond JA, Batchelar DL. Optimization of high-dose-rate cervix brachytherapy applicator placement: the benefits of intraoperative ultrasound guidance. Brachytherapy 2008; 7: 248-53. (Pubitemid 351957934)
7. Stock RG, Chan K, Terk M, Dewyngaert JK, Stone NN, Dottino P. A new technique for performing Syed-Neblett template interstitial implants for gynecologic malignancies using transrectal-ultrasound guidance. Int J Radiat Oncol Biol Phys 1997; 37: 819-25. (Pubitemid 27181314)
8. Weitmann HD, Knocke TH, Waldhäusl C, Pötter R. Ultrasound-guided interstitial Brachytherapy in the treatment of advanced vaginal recurences from cervical and endometrial carcinoma. Strahlenther Onkol 2006; 182: 86-95. (Pubitemid 43177193)
9. Van Dyk S, Narayan K, Fisher R, Bernshaw D. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound. Int J Radiat Oncol Biol Phys 2009; 75: 64-70.
10. Datta NR, Srivastava A, Maria Das KJ, Gupta A, Rastogi N. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer. Brachytherapy 2006; 5: 223-9. (Pubitemid 44755490)
11. Shin KH, Kim TH, Cho JK, Kim JY, Park SY, Park SY, et al. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose volume parameters. Int J Radiat Oncol Biol Phys 2006; 64: 197-204. (Pubitemid 41831227)
12. Mai J, Rownd J, Erickson B. CT-guided high-dose-rate dose prescription for cervical carcinoma: the importance of uterine wall thickness. Brachytherapy 2002; 1: 27-35. (Pubitemid 37329426)
13. Weitmann HD, Pötter R, Waldhäusl C, Nechvile E, Kirisits C, Knocke TH. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman Packing: clinical experience and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2005; 62: 468-78. (Pubitemid 40704464)
14. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU referencepoint estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2005; 62: 131-7. (Pubitemid 40591934)
15. Sun LM, Huang EY, Ko SF, Wang CJ, Leung SW, Lin H, et al. Computertomography-assisted three-dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer. Radiother Oncol 2004; 71: 333-7. (Pubitemid 38686672)
16. Schoeppel SL, Ellis JH, LaVigne ML, Schea RA, Roberts JA. Magnetic resonance imaging during intracavitary gynecologic brachytherapy. Int J Radiat Oncol Biol Phys 1992; 23: 169-74.
17. Tardivon AA, Kinkel K, Lartigau E, Masselot J, Gerbaulet AP, Vanel D. MR imaging during intracavitary brachytherapy of vaginal and cervical cancer: preliminary results. Radiographics 1996; 16: 1363-70. (Pubitemid 126448187)
18. Viswanathan AN, Cormack R, Holloway CL, Tanaka C, O'Farrell D, Devlin PM, et al. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys 2006; 66: 91-9. (Pubitemid 44175660)
19. Wachter-Gerstner N, Wachter S, Reinstadler E, Fellner C, Knocke TH, Wambersie A, et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol 2003; 68: 269-76. (Pubitemid 38373427)
20. Pötter R, Dimopoulos J, Georg P, Lang S, Waldhäusl C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007; 83: 148-55. (Pubitemid 46783926)
21. Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magné N, et al. MRIbased low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol 2010; 96: 161-5.
22. De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van Limbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2008; 88: 217-26.
23. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-Guided 3D Optimization Significantly Improves DVH Parameters of Pulsed-Dose-Rate Brachytherapy in Locally Advanced Cervical Cancer. Int J Radiat Oncol Biol Phys 2008; 71: 756-64.
24. Boss EA, Barentsz JO, Massuger LF, Boonstra H. The role of MR imaging in invasive cervical carcinoma. Eur Radiol 2000; 10: 256-70. (Pubitemid 30136826)
25. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995; 86: 43-50.
26. Hricak H, Gatsonis C, Coakley FV, Snyder B, Reinhold C, Schwartz LH, et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation-ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology 2007; 245: 491-8. (Pubitemid 47612531)
27. Mitchell DG, Snyder B, Coakley F, Reinhold C, Thomas G, Amendola M, et al. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J Clin Oncol 2006; 24: 5687-94. (Pubitemid 46631310)
28. Dimopoulos JC, Schard G, Berger D, Lang S, Goldner G, Helbich T, et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, patho-anatomical structures and organs at risk. Int J Radiat Oncol Biol Phys 2006; 64: 1380-8.
29. Podobnik J, Kocijancic I, Kovac V, Sersa I. 3T MRI in evaluation of asbestosrelated thoracic diseases-preliminary results. Radiol Oncol 2010; 44: 92-6.
30. Sofic A, Beslic S, Sehovic N, Caluk J, Sofic D. MRI in evaluation of perianal fistulae. Radiol Oncol 2010; 44: 220-7.
31. Dimopoulos JC, Schirl G, Baldinger A, Helbich TH, Pötter R, et al. MRI assessment of cervical cancer for adaptive radiotherapy. Strahlenther Onkol 2009; 185: 282-7.
32. Hellebust TP, Kirisits C, Berger D, Pérez-Calatayud J, De Brabandere M, De Leeuw A, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: Considerations and pitfalls in comissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010; 96: 153-60.
33. Petric P, Hudej R, Music M. MRI assisted cervix cancer brachytherapy preplanning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study. J Contemp Brachyther 2009; 1: 163-9.
34. Kouwenhoven E, Giezen M, Struikmans H. Measuring the similarity of target volume delineations independent of the number of observers. Phys Med Biol 2009; 54: 2863-73.
35. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986; 1: 307-10. (Pubitemid 16134762)
36. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-60. (Pubitemid 29425900)
37. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-68.
38. Georg D, Kirisits C, Hillbrand M, Dimopoulos J, Pötter R. Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys 2008; 71: 1272-8.
39. Lichy MP, Wietek BM, Mugler JP 3rd, Horger W, Menzel MI, Anastasiadis A, et al. Magnetic resonance imaging of the body trunk using a single-slab, 3-dimensional, T2-weighted turbo-spin-echo sequence with high sampling efficiency (SPACE) for high spatial resolution imaging: initial clinical experiences. Invest Radiol 2005; 40: 754-60. (Pubitemid 41690431)
40. Fütterer JJ, Yakar D, Strijk SP, Barentsz JO. Preoperative 3T MR imaging of rectal cancer: local staging accuracy using a two-dimensional and threedimensional T2-weighted turbo spin echo sequence. Eur J Radiol 2008; 65: 66-71.
41. Kim H, Lim JS, Choi JY, Park J, Chung YE, Kim MJ, et al. Rectal cancer: comparison of accuracy of local-regional staging with two-and three-dimensional preoperative 3-T MR imaging. Radiology 2010; 254: 485-92.
42. Rosenkrantz AB, Neil J, Kong X, Melamed J, Babb JS, Taneja SS, et al. Prostate cancer: Comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection. AJR Am J Roentgenol 2010; 194: 446-52.
43. Arizono S, Isoda H, Maetani YS, Hirokawa Y, Shimada K, Nakamoto Y, et al. High-spatial-resolution three-dimensional MR cholangiography using a high-sampling-efficiency technique (SPACE) at 3T: Comparison with the conventional constant flip angle sequence in healthy volunteers. J Magn Res Imaging 2008; 28: 685-90.
44. Arizono S, Isoda H, Maetani YS, Hirokawa Y, Shimada K, Nakamoto Y, et al. High spatial resolution 3D MR cholangiography with high sampling efficiency technique (SPACE): Comparison of 3 T vs. 1.5 T. Eur J Radiol 2010; 73: 114-8.
45. Baumert B, Wörtler K, Steffinger D, Schmid GP, Schmidt GP, Reiser MF, Baur-Melnyk A. Assessment of the internal craniocervical ligaments with a new magnetic resonance imaging sequence: three dimensional turbo spin echo with variable flip-angle distribution (SPACE). Magn Res Imaging 2009; 27: 954-60.
46. Young JY, Yoon YC, Kwon JW, Ahn JH, Choe BK. Diagnosis of internal derangement of the knee at 3.0 T MR imaging: 3D isotropic intermediate-weighted versus 2D sequences. Radiology 2009; 253: 780-7.
47. Young JY, Yoon YC, Choi SH, Kwon JW, Yoo J, Choe BK. Three-dimensional isotropic shoulder MR arthrography for the diagnosis of labral lesions at 3.0 T. Radiology 2009; 250: 498-505.
48. Gerbaulet A, Pötter R, Haie-Meder C. Cervix cancer. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO handbook of brachytherapy. Brussels: European Society of Therapeutic Radiology and Oncology; 2002. p 301-63.
49. Guedea F, Ellison T, Venselaar J, Borras JM, Hoskin P, Poetter R, et al. Overview of brachytherapy resources in Europe: a survey of patterns of care study for brachytherapy in Europe. Radiother Oncol 2007; 82: 50-4. (Pubitemid 46116790)
50. Guedea F, Venselaar J, Hoskin P, Hellebust TP, Peiffert D, Londres B, et al. Patterns of care for brachytherapy in Europe: updated results. Radiother Oncol 2010; 97: 514-20.
51. Viswanathan AN, Erickson BA. Three-dimensional imaging in gynaecological brachytherapy: a survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys 2010; 76: 104-9.
52. Dimopoulos JC, De Vos V, Berger D, Dumas I, Kirisits C, Shenfield CB, et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol 2009; 91: 166-72.
53. Lang S, Nulens A, Briot E, Kirisits C, De Brabandere M, Dumas I, Dimopoulos J, et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol 2006; 78: 185-93. (Pubitemid 43344179)
54. Petric P, Dimopoulos J, Kirisits C, Berger D, Hudej R, Pötter R. Inter-and intraobserver variation in HR-CTV contouring: Intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol 2008; 89: 164-71.
55. Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV. Definition of the prostate in CT and MRI: a multiobserver study. Int J Radiat Oncol Biol Phys 1999; 43: 57-66. (Pubitemid 29065832)
56. Struikmans H, Warlam-Rodenhuis C, Stam T, Stapper G, Tersteeg RJ, Bol GH, et al. Interobserver variability of clinical target volume delineation of glandular breast tissue and of boost volume in tangential breast irradiation. Radiother Oncol 2005; 76: 293-9. (Pubitemid 41394280)
57. Hurkmans CW, Borger JH, Pieters BR, Russell NS, Jansen EP, Mijnheer BJ. Variability in target volume delineation on CT scans of the breast. Int J Radiat Oncol Biol Phys 2001; 50: 1366-72. (Pubitemid 32727816)
58. Weiss E, Richter S, Krauss T, Metzelthin SI, Hille A, Pradier O, et al. Conformal radiotherapy planning of cervix carcinoma: differences in the delineation of target volume. A comparison between gynaecologic and radiation oncologists. Radiother Oncol 2003; 67: 87-95. (Pubitemid 36570444)
59. Tanderup K, Hellebust TP, Lang S, Granfeldt J, Pötter R, Lindegaard JC, et al. Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol 2008; 98: 156-63.